Serious Adverse Events Associated with Hydroxychloroquine Amidst COVID-19 Pandemic: Case Series and Literature Review

被引:3
作者
Abdelmaseih, Ramy [1 ]
Abdelmasih, Randa [1 ]
Hasan, Mustajab [1 ]
Tadepalli, Srikanth [1 ]
Patel, Jigar [2 ]
机构
[1] Univ Cent Florida, Coll Med, Ocala Reg Med Ctr, Internal Med, Ocala, FL 34471 USA
[2] Ocala Reg Med Ctr, Cardiol, Ocala, FL USA
关键词
hydroxychloroquine; qt prolongation; torsades de pointer; ventricular tachycardia;
D O I
10.7759/cureus.8415
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
COVID-19 represents a global health crisis. Several studies are evaluating potential therapies including hydroxychloroquine (HCQ) which is given to patients based on limited observational evidence. However, it can cause serious adverse events. Moreover, recent studies showed no benefits due to HCQ. We present two COVID-19 patients treated with HCQ and had adverse events.
引用
收藏
页数:6
相关论文
共 8 条
[1]  
[Anonymous], 2020, OUTCOMES HYDROXYCHLO
[2]  
Borba MGS, 2020, CHLOROQUINE DIPHOSPH
[3]  
Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03
[4]   Determinants of Prolonged QT Interval and Their Contribution to Sudden Death Risk in Coronary Artery Disease The Oregon Sudden Unexpected Death Study [J].
Chugh, Sumeet S. ;
Reinier, Kyndaron ;
Singh, Tejwant ;
Uy-Evanado, Audrey ;
Socoteanu, Carmen ;
Peters, Dawn ;
Mariani, Ronald ;
Gunson, Karen ;
Jui, Jonathan .
CIRCULATION, 2009, 119 (05) :663-670
[5]  
Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI [10.1016/j.ijantimicag.2020.105949, 10.1016/j.ijantimicag.2020.106063]
[6]  
Mahevas M, 2020, NO EVIDENCE CLIN EFF
[7]  
Molina JM, 2002, MED MALADIES INFECT
[8]   Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review [J].
Sanders, James M. ;
Monogue, Marguerite L. ;
Jodlowski, Tomasz Z. ;
Cutrell, James B. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18) :1824-1836